Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer

Journal of Biomedical Nanotechnology

Volumn 9, Issue 7, 2013, Pages 1146-1154

  Saxena, Vipin ^a   Hussain, Muhammad Delwar ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Curcumin; Multidrug resistance; Ovarian cancer; P glycoprotein; Poloxamer 407; TPGS

Indexed keywords

CURCUMIN; MULTIDRUG RESISTANCE; OVARIAN CANCERS; P-GLYCOPROTEIN; POLOXAMER 407; TPGS;

DIFFERENTIAL SCANNING CALORIMETRY; DISEASES; ENCAPSULATION; ENZYME INHIBITION; FILM PREPARATION; GLYCOPROTEINS; LOADING; POLYMERS; X RAY POWDER DIFFRACTION;

MICELLES;

CURCUMIN; D ALPHA TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE; MACROGOL; POLOXAMER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG UPTAKE; MICELLE; NANOENCAPSULATION; OVARY CANCER; PARTICLE SIZE; X RAY DIFFRACTION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CURCUMIN; DELAYED-ACTION PREPARATIONS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICELLES; NANOCAPSULES; OVARIAN NEOPLASMS; POLOXAMER; POLYETHYLENE GLYCOLS; TREATMENT OUTCOME; VITAMIN E;

EID: 84880545197     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1632     Document Type: Article

References (59)

1. F. Wang, D. Zhang, Q. Zhang, Y. Chen, D. Zheng, L. Hao, C. Duan, L. Jia, G. Liu, and Y. Liu, Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxelpolymer micelles to overcome multi-drug resistance. Biomaterials 32, 9444 (2011).
2. B. C. Baguley, Multiple drug resistance mechanisms in cancer. Molecular Biotechnology 46, 308 (2010).
3. P. Borst, R. Evers, M. Kool, and J. Wijnholds, A family of drug transporters: The multidrug resistance-associated proteins. Journal of the National Cancer Institute 92, 1295 (2000).
4. D. D. Ross, Novel mechanisms of drug resistance in leukemia. Leukemia 14, 467 (2000).
5. A. Goel, A. B. Kunnumakkara, and B. B Aggarwal, Curcumin as "Curecumin:" From kitchen to clinic. Biochem. Pharmacol. 75, 787 (2008).
6. A. B. Kunnumakkara, P. Anand, and B. B. Aggarwal, Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 269, 199 (2008).
7. T. Das, G. Sa, B. Saha, and K. Das, Multifocal signal modulation therapy of cancer: Ancient weapon, modern targets. Mol. Cell. Biochem. 336, 85 (2010).
8. V. Basile, E Ferrari, S. Lazzari, S. Belluti, F. Pignedoli, and C. Imbriano, Curcumin derivatives: Molecular basis of their anticancer activity. Biochem. Pharmacol. 78, 1305 (2009).
9. B. B. Aggarwal, A. Kumar, and A. C. Bharti, Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 23, 363 (2003).
10. S. Prakobwong, S. C. Gupta, J. H. Kim, Sung, B. P. Pinlaor, Y. Hiraku, S. Wongkham, B. Sripa, S. Pinlaor, and B. B. Aggarwal, Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways. Carcinogenesis 32, 1372 (2011).
11. H. J. Kang, S. H. Lee, J. E. Price, and L. S. Kim, Curcumin suppresses the paclitaxel-induced nuclear factor-kappa B in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model. Breast J. 15, 223 (2009).
12. S. Zheng and A. Chen, Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro. Biochem. J. 384, 149 (2004).
13. J. Zhang, T. Zhang, X. Ti, J. Shi, C. Wu, X. Ren, and H. Yin, Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway. Biochem. Biophys. Res. Commun. 399, 1 (2010).
14. X. Q. Tang, H. Bi, J. Q. Feng, and J. G. Cao, Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharmacol. Sin. 26, 1009 (2005).
15. T. Efferth, M. Davey, A. Olbrich, G. Rucker, E. Gebhart, and E. R. Davey, Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. Blood Cells Mol. Dis. 28, 160 (2002).
16. J. J. Lu, Y. J. Cai, and J. Ding, The short-time treatment with curcumin sufficiently decreases cell viability, induces apoptosis and copper enhances these effects in multidrug-resistant K562/A02 cells. Mol. Cell. Biochem. 360, 253 (2012).
17. B. H. Choi, C. G. Kim, Y. Lim, S. Y. Shin, and Y. H. Lee, Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett. 259, 111 (2008).
18. S. Anuchapreeda, P. Leechanachai, M. M. Smith, S. V. Ambudkar, and P. N. Limtrakul, Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem. Pharmacol. 64, 573 (2002).
19. S. Ganta and M. Amiji, Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol. Pharm. 6, 928 (2009).
20. N. Romiti, R. Tongiani, F. Cervelli, and E. Chieli, Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. Life Sci. 62, 2349 (1998).
21. T. Nabekura, S. Kamiyama, and S. Kitagawa, Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem. Biophys. Res. Commun. 327, 866 (2005).
22. P. Anand, A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal, Bioavailability of curcumin: Problems and promises. Mol. Pharm. 4, 807 (2007).
23. H. Cho and G. S. Kwon, Polymeric micelles for neoadjuvant cancer therapy and tumor-primed optical imaging. ACS Nano 5, 8721 (2011).
24. C. Oerlemans, W. Bult, M. Bos, G. Storm, J. F. Nijsen, and W. E. Hennink, Polymeric micelles in anticancer therapy: Targeting, imaging and triggered release. Pharm. Res. 27, 2569 (2010).
25. H. C. Shin, A. W. Alani, D. A. Rao, N. C. Rockich, and G. S. Kwon, Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs. J. Control. Release. 140, 294 (2009).
26. M. Yokoyama, Polymeric micelles as a new drug carrier system and their required considerations for clinical trials. Expert. Opin. Drug. Deliv. 7, 145 (2010).
27. V. Saxena and M. D. Hussain, Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer. Int. J. Nanomedicine 7, 713 (2012).
28. V. P. Torchilin, Structure and design of polymeric surfactant-based drug delivery systems. J. Control Release 73, 137 (2001).
29. H. Maeda, G. Y. Bharate, and J. Daruwalla, Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur. J. Pharm. Biopharm. 71, 409 (2009).
30. C. Gong, S. Deng, Q. Wu, Xiang, M. X. Wei, L. Li, X. Gao, B. Wang, L. Sun, Y. Chen, Y. Li, L. Liu, Z. Qian, and Y. Wei, Biomaterials 34, 1413 (2013).
31. M. Gou, K. Men, H. Shi, Xiang, M. J. Zhang, J. Song, J. Long, Y. Wan, F. Luo, X. Zhao, and Z. Qian, Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 3, 1558 (2011).
32. L. Liu, L. Sun, W. Guo, Wu, Q. L. Li, Y. Chen, Y. Li, C. Gong, Z. Qian, and Y. Wei, Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. Int. J. Pharm. (2012).
33. S. Podaralla, R. Averineni, M. Alqahtani, and O. Perumal, Synthesis of novel biodegradable methoxy poly(ethylene glycol)-zein micelles for effective delivery of curcumin. Mol. Pharm. 9, 2778 (2012).
34. K. Wang, T. Zhang, L. Liu, Wang, X. P. Wu, Z. Chen, C. Ni, J. Zhang, F. Hu, and J. Huang, Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells. Int. J. Nanomedicine 7, 4487 (2012).
35. W. Zhang, Y. Shi, Y. Chen, J. Ye, X. Sha, and X. Fang, The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models. Biomaterials 32, 5934 (2011).
36. E. V. Batrakova, S. Li, Y. Li, V. Y. Alakhov, W. F. Elmquist, and A. V. Kabanov. Distribution kinetics of a micelle-forming block copolymer Pluronic P85. J. Control. Release. 100, 389 (2004).
37. J. M. Grindel, T. Jaworski, O. Piraner, R. M. Emanuele, and M. Balasubramanian, Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans. J. Pharm. Sci. 91, 1936 (2002).
38. S. J. Huang, S. L. Sun, T. H. Feng, K. H. Sung, W. L. Lui, and L. F. Wang, Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier. Eur. J. Pharm. Sci. 38, 64 (2009).
39. E. A. Pec, Z. G. Wout, and T. P. Johnston, Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat. J. Pharm. Sci. 81, 626 (1992).
40. K. T. Oh, T. K. Bronich, and A. V. Kabanov, Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers. J. Control. Release 94, 411 (2004).
41. W. Zhang, Y. Shi, Y. Chen, J. Ye, X. Sha, and X. Fang, Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials 32, 2894 (2011).
42. V. Alakhov, E. Moskaleva, E. V. Batrakova, and A. V. Kabanov, Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjug. Chem. 7, 209 (1996).
43. E. Batrakova, S. Lee, S. Li, A. Venne, V. Alakhov, and A. Kabanov, Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm. Res. 16, 1373 (1999).
44. Z. Zhang, S. Tan, and S. S. Feng, Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 33, 4889 (2012).
45. J. M. Dintaman and J. A. Silverman, Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm. Res. 16, 1550 (1999).
46. C. Constantinou, C. M. Neophytou, P. Vraka, J. A. Hyatt, K. A. Papas, and A. I. Constantinou, Induction of DNA damage and caspase-independent programmed cell death by vitamin E. Nutrition and Cancer 64, 136 (2012).
47. Y. Mi, Y. Liu, and S. S. Feng, Formulation of Docetaxel by folic acid-conjugated d-alpha-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. Biomaterials 32, 4058 (2011).
48. L. Mu, T. A. Elbayoumi, and V. P. Torchilin, Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int. J. Pharm. 306, 142 (2005).
49. Z. G. Gao, H. D. Fain, and N. Rapoport, Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J. Control. Release. 102, 203 (2005).
50. T. Kokubo and H. Takadama, How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 27, 2907 (2006).
51. K. S. Kim and S. J. Park, Effect of porous silica on sustained release behaviors of pH sensitive pluronic F127/poly(acrylic acid) hydrogels containing tulobuterol. Colloids Surf. B Biointerfaces 80, 240 (2010).
52. Y. Guan, J. Huang, L. Zuo, J. Xu, L. Si, J. Qiu, and G. Li, Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism. Arch. Pharm. Res. 34, 1719 (2011).
53. E. M. Collnot, C. Baldes, M. F. Wempe, Kappl, R. J. Huttermann, J. A. Hyatt, K. J. Edgar, U. F. Schaefer, and C. M. Lehr, Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: Influence on ATPase activity and membrane fluidity. Mol. Pharm. 4, 465 (2007).
54. E. V. Batrakova, S. Li, S. V. Vinogradov, V. Y. Alakhov, D. W. Miller, and A. V. Kabanov, Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. J. Pharm. Exp. Thera. 299, 483 (2001).
55. Z. Wei, J. Hao, S. Yuan, Li, Y. W. Juan, X. Sha, and X. Fang, Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: Formulation, optimization and in vitro characterization. Int. J. Pharm. 376, 176 (2009).
56. J. Panyam, W. Z. Zhou, S. Prabha, S. K. Sahoo, and V. Labhasetwar, Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J. 16, 1217 (2002).
57. A. A. Gabizon, Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res. 52, 891 (1992).
58. Y. Y. Diao, H. Y. Li, Y. H. Fu Han, M. Y. L. Hu, H. L. Jiang, Y. Tsutsumi, Q. C. Wei, D. W. Chen, and J. Q. Gao, Doxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cells. Int. J. Nanomedicine 6, 1955 (2011).
59. Y. Wang, L. Chen, Y. Ding, and W. Yan, Oxidized phospholipid based pH sensitive micelles for delivery of anthracyclines to resistant leukemia cells in vitro. Int. J. Pharm. 422, 409 (2012).